Ikarian Capital, LLC - ABCELLERA BIOLOGICS INC ownership

ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 118 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 1.2%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of ABCELLERA BIOLOGICS INC
ValueSharesWeighting
Q2 2021$1,621,00073,7000.13%
Other shareholders
ABCELLERA BIOLOGICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Founders Fund VII Management, LLC 3,773,530$75,584,00086.10%
Gruss & Co., LLC 430,407$8,625,00024.12%
SB Management Ltd 9,817,190$196,736,00020.16%
GUARDIAN CAPITAL ADVISORS LP 3,836,414$76,767,0007.97%
Intellectus Partners, LLC 1,223,429$24,518,0005.93%
HARVARD MANAGEMENT CO INC 4,105,095$82,266,0004.82%
ArchPoint Investors 461,289$9,244,0002.77%
Belmont Capital, LLC 150,000$3,006,0002.44%
CLOUGH CAPITAL PARTNERS L P 971,297$19,465,0001.18%
Orbimed Advisors 4,180,768$83,783,0000.92%
View complete list of ABCELLERA BIOLOGICS INC shareholders